Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 315.76% Upside As of ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

LIBERTY® Continues to Gain Commercial Traction and Exposure as Part of Its Limited Market Release (LMR) in the US ...

As adults, there are so many resources available to us to break into the world of programming and coding. From organizations like General Assembly and the hundreds of localized coding bootcamps, you ...

Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...

As a programming teaching material for children,"Arduboy" to make your own 8-bit gameWhile various things are coming out, easy-to-attach electronic tooling for children who can move toys by dragging ...

Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...

Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 ...